SCHEMBL13974792

SCHEMBL13974792

NC(=O)c1c(C(F)F)nn(-c2ccccc2)c1N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.56
BRAF P15056 1/20 0.56
KDR P35968 1/20 0.56
HPGD P15428 2/20 0.48
RIPK2 O43353 4/20 0.47
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HSD17B10 Q99714 1/20 0.41
LMNA P02545 2/20 0.40
TDP2 O95551 1/20 0.40
RCE1 Q9Y256 1/20 0.39
PLK4 O00444 1/20 0.39
ROCK2 O75116 1/20 0.39
RPS6KA5 O75582 1/20 0.39
MAP4K4 O95819 1/20 0.39
INSR P06213 1/20 0.39
ROS1 P08922 1/20 0.39
PIM1 P11309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11544508 0.80 SRC (0.62) SRCBRAFKDRHPGDRIPK2
SCHEMBL2546507 0.77 HPGD (0.71) SRCBRAFKDRHPGDRIPK2
SCHEMBL15568452 0.77 POLB (0.44) HPGDKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL10568444 0.77 SRC (0.56) SRCBRAFKDRHPGDRIPK2
SCHEMBL2545006 0.73 GAA (0.56) SRCBRAFKDRHPGDRIPK2
SCHEMBL13974570 0.73 HPGD (0.58) SRCBRAFKDRHPGDRIPK2
SCHEMBL31623412 0.73 CYP2C9 (0.38) HPGDKMT2AMEN1ALDH1A1MAPK14
SCHEMBL16344251 0.72 POLB (0.50) HPGDKMT2AKDM4EMEN1ALDH1A1
SCHEMBL13860340 0.72 GAA (0.57) HPGDKMT2AKDM4EMEN1ALDH1A1
SCHEMBL14833703 0.71 SRC (1.00) SRCBRAFKDRHPGDRIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012158413-A2 PYRROLIDINYL UREA AND PYRROLIDINYL THIOUREA COMPOUNDS AS TRKA KINASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2012-11-22 WO disclosed